Literature DB >> 14688819

Pulmonary function after autologous bone marrow transplantation in children: a long-term prospective study.

P Frisk1, J Arvidson, L-E Bratteby, H Hedenström, G Lönnerholm.   

Abstract

We performed serial pulmonary function tests (PFTs) consisting of spirometry and diffusing capacity in 26 children after BMT. The median follow-up was 10 years. The influence of total body irradiation (TBI) on long-term pulmonary function was of particular interest. In the 20 children who had received TBI, after an initial decrease the PFTs showed recovery, but the mean lung volumes were still significantly decreased 5 years after BMT at 10% below baseline. The proportions of children with restrictive impairment 5 and 10 years after BMT were 20 and 21%, respectively. Only one child was diagnosed with obstructive impairment. The proportions of children with isolated diffusing impairment at 5 and 10 years were 7/20 (35%) and 7/13 (54%), respectively. Six children had received chemotherapy only and showed isolated diffusing impairment as the only long-term sequela in 4/5 and 1/3 at 5 and 10 years. Our main finding was that there was little change in PFTs 1-10 years after BMT. TBI was associated with persistently decreased lung volumes in a proportion of patients, whereas chemotherapy also might have been of importance for the development of impaired gas exchange.

Entities:  

Mesh:

Year:  2004        PMID: 14688819     DOI: 10.1038/sj.bmt.1704393

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  6 in total

1.  Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma.

Authors:  Anne Stone; Danielle Novetsky Friedman; Brian H Kushner; Suzanne Wolden; Shakeel Modak; Michael P LaQuaglia; Jessica Costello; Xian Wu; Nai-Kong Cheung; Charles A Sklar
Journal:  Pediatr Blood Cancer       Date:  2019-08-12       Impact factor: 3.167

2.  Pulmonary function after hematopoietic stem cell transplantation is significantly better in pediatric recipients following reduced toxicity compared with myeloablative conditioning.

Authors:  R Majzner; C Sandoval; A J Dozor; Z Jin; C van de Ven; R Dalal; E Morris; L Harrison; K Wolownik; S Fabricatore; L A Baxter-Lowe; M S Cairo
Journal:  Bone Marrow Transplant       Date:  2016-06-20       Impact factor: 5.483

3.  Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.

Authors:  Yi-Bin Chen; Andrew A Lane; Brent Logan; Xiaochun Zhu; Görgün Akpek; Mahmoud Aljurf; Andrew Artz; Christopher N Bredeson; Kenneth R Cooke; Vincent T Ho; Hillard M Lazarus; Richard Olsson; Wael Saber; Philip McCarthy; Marcelo C Pasquini
Journal:  Biol Blood Marrow Transplant       Date:  2015-02-14       Impact factor: 5.742

4.  Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk Neuroblastoma.

Authors:  Anne Stone; Danielle Novetsky Friedman; Stefan Worgall; Brian H Kushner; Suzanne Wolden; Shakeel Modak; Michael P LaQuaglia; Xian Wu; Nai-Kong Cheung; Charles A Sklar
Journal:  J Pediatr Hematol Oncol       Date:  2017-10       Impact factor: 1.289

Review 5.  Pulmonary outcomes in survivors of childhood cancer: a systematic review.

Authors:  Tseng-Tien Huang; Melissa M Hudson; Dennis C Stokes; Matthew J Krasin; Sheri L Spunt; Kirsten K Ness
Journal:  Chest       Date:  2011-03-17       Impact factor: 9.410

6.  Chemotherapeutic agents increase the risk for pulmonary function test abnormalities in patients with multiple myeloma.

Authors:  Jarrod T Bruce; Jerry M Tran; Gary Phillips; Pat Elder; John G Mastronarde; Steven M Devine; Craig C Hofmeister; Karen L Wood
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.